Schedule 13G ownership disclosure

NEKTAR THERAPEUTICS

Common Stock, par value $0.0001 per share · CUSIP: 640268108

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TCG Crossover GP II, LLC

    Shares: 0 · Class: 0%

  • TCG Crossover Fund II, L.P.

    Shares: 0 · Class: 0%

  • Chen Yu

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-283066
Form type
SCHEDULE 13G/A
Filer
NEKTAR THERAPEUTICS
CIK
CIK 906709
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub